Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006173764> ?p ?o ?g. }
- W2006173764 endingPage "F819" @default.
- W2006173764 startingPage "F808" @default.
- W2006173764 abstract "Bardoxolone methyl is an antioxidant inflammation modulator acting through induction of Keap1-Nrf2 pathway. Results from a recent phase IIb clinical trial reported that bardoxolone methyl was associated with improvement in the estimated glomerular filtration rate in patients with advanced chronic kidney disease and Type 2 diabetes. However, increases in albuminuria, serum transaminase, and frequency of adverse events were noted. We studied the effect of 3-mo treatment with RTA 405, a synthetic triterpenoid analog of bardoxolone methyl in Zucker diabetic fatty rats with overt Type 2 diabetes. Rats were treated from 3 mo of age with vehicle, RTA 405, ramipril, or RTA 405 plus ramipril. RTA 405 caused severe changes in food intake and diuresis with decline in body weight, worsening of dyslipidemia, and increase in blood pressure. Early elevation in serum transaminase was followed by liver injury. RTA 405 worsened proteinuria, glomerulosclerosis, and tubular damage. Ramipril was renoprotective, but when given with RTA 405 it was not able to limit its worsening effects. These data could be due to degradation products in the drug substance used, as disclosed by the company once the study was concluded. To overcome such a drawback, the company offered to test dh404, a variant of RTA 405, in Zucker diabetic fatty rats. The dh404 did not display beneficial effects on proteinuria, glomerulosclerosis, and interstitial inflammation. Rather, kidneys from three rats receiving dh404 showed the presence of a granulomatous and inflammatory process reminiscent of a pseudotumor. Altogether these data raise serious concerns on the use of bardoxolone analogs in Type 2 diabetic nephropathy." @default.
- W2006173764 created "2016-06-24" @default.
- W2006173764 creator A5001678867 @default.
- W2006173764 creator A5023556434 @default.
- W2006173764 creator A5035442609 @default.
- W2006173764 creator A5038695071 @default.
- W2006173764 creator A5044187420 @default.
- W2006173764 creator A5051449033 @default.
- W2006173764 creator A5078814791 @default.
- W2006173764 creator A5080151381 @default.
- W2006173764 creator A5087225829 @default.
- W2006173764 creator A5090115261 @default.
- W2006173764 date "2013-03-15" @default.
- W2006173764 modified "2023-09-29" @default.
- W2006173764 title "Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects" @default.
- W2006173764 cites W1966060541 @default.
- W2006173764 cites W1968446955 @default.
- W2006173764 cites W1987669162 @default.
- W2006173764 cites W1999894132 @default.
- W2006173764 cites W2000178617 @default.
- W2006173764 cites W2004832721 @default.
- W2006173764 cites W2020267609 @default.
- W2006173764 cites W2040499888 @default.
- W2006173764 cites W2042069668 @default.
- W2006173764 cites W2043536329 @default.
- W2006173764 cites W2044078040 @default.
- W2006173764 cites W2044773944 @default.
- W2006173764 cites W2048594557 @default.
- W2006173764 cites W2056976690 @default.
- W2006173764 cites W2059946291 @default.
- W2006173764 cites W2092086453 @default.
- W2006173764 cites W2100850228 @default.
- W2006173764 cites W2111554856 @default.
- W2006173764 cites W2126146739 @default.
- W2006173764 cites W2133690273 @default.
- W2006173764 cites W2134172788 @default.
- W2006173764 cites W2136089239 @default.
- W2006173764 cites W2140558175 @default.
- W2006173764 cites W2145161910 @default.
- W2006173764 cites W2152298559 @default.
- W2006173764 cites W2153582942 @default.
- W2006173764 cites W2165355897 @default.
- W2006173764 cites W3149144210 @default.
- W2006173764 doi "https://doi.org/10.1152/ajprenal.00376.2012" @default.
- W2006173764 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23136004" @default.
- W2006173764 hasPublicationYear "2013" @default.
- W2006173764 type Work @default.
- W2006173764 sameAs 2006173764 @default.
- W2006173764 citedByCount "90" @default.
- W2006173764 countsByYear W20061737642013 @default.
- W2006173764 countsByYear W20061737642014 @default.
- W2006173764 countsByYear W20061737642015 @default.
- W2006173764 countsByYear W20061737642016 @default.
- W2006173764 countsByYear W20061737642017 @default.
- W2006173764 countsByYear W20061737642018 @default.
- W2006173764 countsByYear W20061737642019 @default.
- W2006173764 countsByYear W20061737642020 @default.
- W2006173764 countsByYear W20061737642021 @default.
- W2006173764 countsByYear W20061737642022 @default.
- W2006173764 countsByYear W20061737642023 @default.
- W2006173764 crossrefType "journal-article" @default.
- W2006173764 hasAuthorship W2006173764A5001678867 @default.
- W2006173764 hasAuthorship W2006173764A5023556434 @default.
- W2006173764 hasAuthorship W2006173764A5035442609 @default.
- W2006173764 hasAuthorship W2006173764A5038695071 @default.
- W2006173764 hasAuthorship W2006173764A5044187420 @default.
- W2006173764 hasAuthorship W2006173764A5051449033 @default.
- W2006173764 hasAuthorship W2006173764A5078814791 @default.
- W2006173764 hasAuthorship W2006173764A5080151381 @default.
- W2006173764 hasAuthorship W2006173764A5087225829 @default.
- W2006173764 hasAuthorship W2006173764A5090115261 @default.
- W2006173764 hasConcept C126322002 @default.
- W2006173764 hasConcept C134018914 @default.
- W2006173764 hasConcept C159641895 @default.
- W2006173764 hasConcept C2776174234 @default.
- W2006173764 hasConcept C2778096610 @default.
- W2006173764 hasConcept C2779561371 @default.
- W2006173764 hasConcept C2779888176 @default.
- W2006173764 hasConcept C2779922275 @default.
- W2006173764 hasConcept C2780091579 @default.
- W2006173764 hasConcept C2781184683 @default.
- W2006173764 hasConcept C555293320 @default.
- W2006173764 hasConcept C71924100 @default.
- W2006173764 hasConcept C84393581 @default.
- W2006173764 hasConcept C98274493 @default.
- W2006173764 hasConceptScore W2006173764C126322002 @default.
- W2006173764 hasConceptScore W2006173764C134018914 @default.
- W2006173764 hasConceptScore W2006173764C159641895 @default.
- W2006173764 hasConceptScore W2006173764C2776174234 @default.
- W2006173764 hasConceptScore W2006173764C2778096610 @default.
- W2006173764 hasConceptScore W2006173764C2779561371 @default.
- W2006173764 hasConceptScore W2006173764C2779888176 @default.
- W2006173764 hasConceptScore W2006173764C2779922275 @default.
- W2006173764 hasConceptScore W2006173764C2780091579 @default.
- W2006173764 hasConceptScore W2006173764C2781184683 @default.
- W2006173764 hasConceptScore W2006173764C555293320 @default.
- W2006173764 hasConceptScore W2006173764C71924100 @default.
- W2006173764 hasConceptScore W2006173764C84393581 @default.